Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones

2025.12.04 21:37

I'm PortAI, I can summarize articles.

Gilead Sciences Inc. (GILD) shares fell 1.90% to $122.62 on Thursday, underperforming compared to competitors. The S&P 500 Index rose 0.11%, while the Dow Jones Industrial Average fell 0.07%. Gilead's stock is 4.72% below its 52-week high. Trading volume was 4.9M, below the 50-day average of 7.3M. Competitors' performances: Johnson & Johnson (JNJ) fell 1.39%, Pfizer Inc. (PFE) rose 0.51%, and Abbott Laboratories (ABT) rose 0.09%. Data source: Dow Jones Market Data, FactSet. Compiled December 4, 2025.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Gilead Sciences Inc. (GILD) slid 1.90% to $122.62 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94. Gilead Sciences Inc. closed 4.72% short of its 52-week high of $128.70, which the company reached on November 20th. The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.39% to $202.48, Pfizer Inc. (PFE) rose 0.51% to $25.70, and Abbott Laboratories (ABT) rose 0.09% to $125.40. Trading volume (4.9 M) remained 2.3 million below its 50-day average volume of 7.3 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-04-25 1637ET